2012 SpeakersAgendaOverviewAgenda2012 Speakers2013 Attendees WSGR website


Conference Agenda

Wednesday, June 11, 2014
Sharon Heights Golf and Country Club
2900 Sand Hill Road
Menlo Park, CA

6:00 – 9:00 p.m.

Medical Device Dinner Interview Geoffrey S. Martha
Senior Vice President, Strategy and Business Development

Join David Cassak in a conversation with Geoffrey S. Martha about Medtronic's US and International Strategies.  Learn about recent transactions completed by Medtronic and how your company may fit into Medtronic's initiatives and focus for the future.

Thursday, June 12, 2014

The Intercontinental Hotel
888 Howard Street
San Francisco, CA

7:00 – 8:00 a.m.

Conference Registration and Continental Breakfast

8:00 – 8:10 a.m.

Welcome, Casey McGlynn, Partner, Wilson Sonsini Goodrich & Rosati

8:10 – 9:10 a.m.

Funding Strategies for Entrepreneurs
Finding capital today is difficult no matter what the stage of the company.  This panel of entrepreneurs and CEOs will share their experiences in the search for capital.  Learn about the types of deals that are getting done today and the requirements that need to be met to be seriously considered for investment.  This panel will discuss the methods and strategies used by leading companies to find capital today and the changing areas of investor interest.

9:10 – 9:30 a.m.


9:30 – 10:30 a.m.

Breakout Session 1

Understanding Corporate Investors and Buyers
Join David Cassak for a discussion with several large Medtech consolidators as they review recent acquisitions, investments and corporate partnering transactions.  Learn about their areas of interest, how they evaluate companies and their appetite for early versus late stage deals. Join a discussion about the differing structures involved including debt versus equity, buyout options, rights of first refusal, and negotiation.

Managing Your Patent Portfolio
Developing the world's best medical technology should be enough, but you're also expected to both patent it and defend it within a shrinking budget. Join a panel of medical technology experts, including a successful serial entrepreneur and experienced in-house and outside patent counsel as they discuss how to build value into an IP portfolio while managing costs in today's challenging Medtech environment. The panel will discuss successful strategies for preparing and prosecuting patent applications inside and outside the US as well as facing the patents of competitors in the most cost-effective ways possible.

10:30 – 10:50 a.m.


10:50 – 11:50 a.m

Breakout Session 2

From Volume to Value—What Payors and Providers Want
Today more than ever, Medtech companies must demonstrate how their devices will both improve care and save the healthcare system money.  The Affordable Care Act has shifted the economic risks of care from the payers to the providers.  Additionally the consolidation of providers is creating much greater purchasing power.  These changes are forcing Medtech companies to find new ways to define clinical and economic benefit.  Join this group of Payers and Providers to learn what attributes your products need to be successful in this new world.

Collaborations Between Japan and Silicon Valley
There is growing interest from Japan to invest in and collaborate with US Medtech companies, incubators and venture funds, many of which are located in Silicon Valley.  For the first time in many years the major Japanese trading companies are focusing on reenergizing their Medtech businesses.  This represents a major opportunity for Silicon Valley startups to seek investments from and partnerships with Japanese businesses.  Join this panel of Japanese experts who will help explain the reasons driving Japan's renewed interest in advanced medical technologies and the resulting possibilities for collaboration.

European Market Access – Is it dead or is there still an opportunity?
The increased regulatory hurdle for CE-marking and the barriers for reimbursement creates a challenging environment to introduce new technologies in Europe. Some may argue that Europe is no longer a feasible first market for entry. In this session we will review the current reality, discuss areas of opportunity and what the formula for success could be.

11:50 a.m. – 12:10 p.m.


12:10 – 1:10 p.m.

Breakout Session 3

International Funding Strategies
Join a panel of experienced executives who have successfully raised capital in Asia and the European Union.  Meet international investors and advisors who can help you fund your company or help you to establish a business in Asia or the European Union.  Learn how these transactions are structured and the reasons that draw international capital to the US and US entrepreneurs to Europe, China, Singapore, Korea, and Japan.

Lean LaunchPad – A Better Startup Strategy
In today's tough funding climate, innovation in science and technology is not enough. The Lean LaunchPad approach to building Medtech startups focuses on innovative business models. The Key is getting founders "out of the building" to solicit direct feedback from potential customers and key stakeholders. This "Lean" approach shifts startup thinking from writing business plans and execution to the early testing of critical hypotheses about the business, allowing adjustments or pivots on little or no capital.  Join Allan May and several CEO's as they discuss the Lean LaunchPad Concept and the things that entrepreneurs need to have in place before they start to look for money.

Management Compensation!
Let's talk about executive compensation for the Medtech executive.  Join a group of compensation experts as they look at recent trends and emerging best practices in compensation.  Participate in a discussion of current salary, stock and bonus structures for management.  Learn about the structure and pitfalls associated with carve out plans and innovative ways to provide management teams compensation for successful exits.

1:10 – 2:40 p.m.


2:40 – 3:40 p.m.

Breakout Session 4

Developing Exit Opportunities
Medtech M&A activity increased last year and this increase continues today.  Although the IPO market for Biotech businesses has been robust, underwriters have only recently begun to actively pitch IPOs to mature Medtech companies. From this vantage point we enter 2014 with hope for both the continued vibrancy of the M&A market and the emergence of a fragile but expanding IPO market for high quality Medtech companies. With this as a background, our panel will explore current investor appetite for Medtech IPOs, the status of the emerging window for public offerings and the likely minimum requirements to be considered an attractive Medtech IPO candidate. The panel will also discuss several of the trends emerging from recent Medtech M&A transactions.

Incubators and Accelerators
There is an increasing number of incubators and accelerators developing new Medtech products today.  We will explore several of these businesses; look at the kinds of companies they are starting and the process they go through in identifying new opportunities and in obtaining the funding needed to bring these ideas to reality. 

Medtech Compliance Workshop
In recent years there has been significant regulatory changes affecting the medical device industry.   These changes make it more important than ever that each company establish an overall compliance program.  Join a panel of experts who will discuss best practices today including adoption of a code of a business conduct, appointment of a compliance officer, managing physician relationships and compensation, understanding the Foreign Corrupt Practices Act and Medicare Anti-Kickback Laws.  In the past several years there have been an increasing number of investigations and suits against small Medtech companies for failure to comply with these complex requirements.  Don't get caught short.

3:40 – 4:00 p.m.


4:00– 5:00 p.m.

Medtech Innovator 2014 with $100,000 cash prize!
Ten semi-finalist companies will be selected between now and June 12th to vie for the title of Medtech Innovator of 2014 and a $100,000 cash prize.  Each company will submit a 1-minute pitch video that will be played for the audience. A panel of active medical device investors will then select four finalist companies to make a longer presentation and give feedback to each of the companies that present. Finally, the audience will select the winner using electronic polling. The winner will receive a $100,000 grand prize, sponsored by RCT Ventures. They will also get a presenting slot at an upcoming IN3 Medical Device conference, and they will be profiled in an upcoming issue of Informa's monthly magazine START-UP: The Review of Emerging Medical Ventures. For those interested in applying, please submit an application at http://medtechinnovator.com/wsgr2014.

5:00 – 6:30 p.m.

Venture Wine Tasting
Join Wilson Sonsini Goodrich & Rosati for wine tasting after the conference. We will be sampling wines from various wineries, with venture capitalists serving as your sommeliers for the event. This is your chance to try some great wine and learn a little bit more about what each of our local venture firms is looking for in its next deal. It's a great pairing—wine with a venture capital twist.